Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis
The Chronic Effects of Low-Load Blood Flow Restriction or Standard of Care Resistance Exercise on Muscle and Neuromuscular Function in Patients With Multiple Sclerosis
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- Blood Flow Restriction
Compared with
- Standard of Care
What it measured
Main measures
Change in Functional Outcomes- 10meter
Day 2, Week 4 and 8, Day 28
Walking and mobilityChange in Functional Outcomes- 6min walk
Day 2, Week 4 and 8, Day 28
Walking and mobilityChange in Functional Outcomes- CST
Day 2, Week 4 and 8, Day 28
Change in Functional Outcomes- 30CST
Day 2, Week 4 and 8, Day 28
Change in Functional Outcomes- MFIS
Day 2, Week 4 and 8, Day 28
Fatigue
Other measures (1)
Changes in Strength
Day 3, Week 4 and 8, Day 29
Physical function
Who could take part
MS (type not specified) · 18 to 55
Show the full criteria
Inclusion criteria
* Females between the ages of 18 to 55 * Diagnosed with Multiple Sclerosis * Expanded Disability Status Score of 0 to 6.5 * Able to walk 10 meters without assistance * Are willing to come in for all 29 testing visits over 14 weeks
Exclusion criteria
* No other known cardiovascular, pulmonary, metabolic, muscular, and/or coronary heart disease * Multiple Sclerosis relapse in the past 30 days * Are not currently undergoing a rehabilitation protocol * Are not currently seeking medical care for a chronic condition that could limit exercise capacity other than multiple sclerosis * Are not currently pregnant
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This research is being done to compare the current standard of care for strength training for patients with Multiple Sclerosis to lightweight resistance training with blood flow restriction.
Papers
Loading reviews and guidelines…
History
Started
Jan 2022
Main results due
Jan 2024
Finished
May 2024